Gilead Sciences, Inc. (GILD)
122.78
-0.40
(-0.32%)
USD |
NASDAQ |
Dec 31, 12:23
Gilead Sciences Research and Development Expense (TTM): 5.734B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Johnson & Johnson | 15.77B |
| Eli Lilly & Co. | 12.56B |
| Merck & Co., Inc. | 14.26B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |